- Home
- LXRX vs LANV Comparison
LXRX vs LANV Comparison
Compare LXRX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- LANV
- Stock Information
- Founded
- LXRX 1995
- LANV 2015
- Country
- LXRX United States
- LANV China
- Employees
- LXRX N/A
- LANV N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- LXRX Health Care
- LANV Finance
- Exchange
- LXRX Nasdaq
- LANV Nasdaq
- Market Cap
- LXRX 228.8M
- LANV 258.1M
- IPO Year
- LXRX 2000
- LANV N/A
- Fundamental
- Price
- LXRX $0.75
- LANV $2.10
- Analyst Decision
- LXRX Buy
- LANV
- Analyst Count
- LXRX 4
- LANV 0
- Target Price
- LXRX $3.67
- LANV N/A
- AVG Volume (30 Days)
- LXRX 3.7M
- LANV 35.8K
- Earning Date
- LXRX 07-31-2025
- LANV 04-30-2025
- Dividend Yield
- LXRX N/A
- LANV N/A
- EPS Growth
- LXRX N/A
- LANV N/A
- EPS
- LXRX N/A
- LANV N/A
- Revenue
- LXRX $31,213,000.00
- LANV $340,211,202.00
- Revenue This Year
- LXRX N/A
- LANV $11.74
- Revenue Next Year
- LXRX N/A
- LANV $11.11
- P/E Ratio
- LXRX N/A
- LANV N/A
- Revenue Growth
- LXRX 1251.21
- LANV N/A
- 52 Week Low
- LXRX $0.28
- LANV $0.91
- 52 Week High
- LXRX $2.45
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- LXRX 61.01
- LANV 45.16
- Support Level
- LXRX $0.64
- LANV $2.02
- Resistance Level
- LXRX $0.77
- LANV $2.19
- Average True Range (ATR)
- LXRX 0.06
- LANV 0.12
- MACD
- LXRX 0.00
- LANV -0.01
- Stochastic Oscillator
- LXRX 76.47
- LANV 32.58
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.